# Safety and Efficacy Study of XPF-001 to Treat Pain Following Wisdom Tooth Extraction

> **NCT00954356** · PHASE2 · COMPLETED · sponsor: **Xenon Pharmaceuticals Inc.** · enrollment: 61 (actual)

## Conditions studied

- Dental Pain

## Interventions

- **DRUG:** XPF-001
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00954356
- **Lead sponsor:** Xenon Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2009-11
- **Final completion:** 2009-12
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2012-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00954356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00954356, "Safety and Efficacy Study of XPF-001 to Treat Pain Following Wisdom Tooth Extraction". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00954356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*